UroGen Pharma Ltd. - Ordinary Shares (URGN) SEC filings
URGN SEC filings moved a median of -0.38% by the close. URGN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the URGN overview →
59 measured URGN SEC filing events.
Where these URGN SEC filings landedvs 59 measured URGN SEC filing reactions
| Middle 50% of URGN SEC filing reactions | -3.93% to +4.79% |
|---|---|
| Median reaction (to close) | -0.38% |
| Measured reactions | 59 |
Point-in-time · zero look-ahead
Half of the 59 URGN SEC filing events with a measured close landed between -3.93% and +4.79%; 49% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K UroGen Pharma Ltd. For: Aug 18 | SEC filing · Form 8-K | -1.77% | -5.85% | |
| Form 10-Q UroGen Pharma Ltd. For: Jun 30 | SEC filing · Form 10-Q | +2.10% | +10.10% | |
| Form 8-K UroGen Pharma Ltd. For: Aug 05 | SEC filing · Form 8-K | +2.10% | +10.10% | |
| Form 8-K UroGen Pharma Ltd. For: Jun 22 | SEC filing · Form 8-K | +1.68% | +0.88% | |
| Form 8-K UroGen Pharma Ltd. For: Jun 02 | SEC filing · Form 8-K | +2.01% | -1.38% | |
| Form ARS UroGen Pharma Ltd. For: Dec 31 | SEC filing · Form ARS | +0.09% | -1.95% | |
| Form 10-Q UroGen Pharma Ltd. For: Mar 31 | SEC filing · Form 10-Q | +2.15% | +4.08% | |
| Form 8-K UroGen Pharma Ltd. For: May 06 | SEC filing · Form 8-K | +2.15% | +4.08% | |
| Form DEF 14A UroGen Pharma Ltd. For: Dec 31 | SEC filing · Form DEF | +3.26% | -2.75% | |
| Form PRE 14A UroGen Pharma Ltd. For: Dec 31 | SEC filing · Form PRE | -0.79% | +9.83% | |
| Form 10-K UroGen Pharma Ltd. For: Dec 31 | SEC filing · Form 10-K | -8.31% | -12.19% | |
| Form 8-K UroGen Pharma Ltd. For: Feb 26 | SEC filing · Form 8-K | -8.31% | -12.19% | |
| Form 8-K UroGen Pharma Ltd. For: Mar 02 | SEC filing · Form 8-K | -8.31% | -12.19% | |
| Form 10-Q UroGen Pharma Ltd. For: Sep 30 | SEC filing · Form 10-Q | +2.98% | +28.77% | |
| Form 8-K UroGen Pharma Ltd. For: Nov 06 | SEC filing · Form 8-K | +2.98% | +28.77% | |
| Form S-3ASR UroGen Pharma Ltd. | SEC filing · Form S-3ASR | -1.79% | +2.74% | |
| Form S-8 UroGen Pharma Ltd. | SEC filing · Form S-8 | -1.79% | +2.74% | |
| Form 8-K UroGen Pharma Ltd. For: Aug 26 | SEC filing · Form 8-K | -1.38% | -1.49% | |
| Form 10-Q UroGen Pharma Ltd. For: Jun 30 | SEC filing · Form 10-Q | -3.00% | -3.83% | |
| Form 8-K UroGen Pharma Ltd. For: Aug 07 | SEC filing · Form 8-K | -3.00% | -3.83% | |
| Form ARS UroGen Pharma Ltd. For: Dec 31 | SEC filing · Form ARS | +0.53% | +1.06% | |
| Form DEF 14A UroGen Pharma Ltd. For: Aug 11 | SEC filing · Form DEF | -0.70% | +0.28% | |
| Form 8-K UroGen Pharma Ltd. For: Jun 30 | SEC filing · Form 8-K | -0.89% | +0.07% | |
| Form 8-K UroGen Pharma Ltd. For: Jun 12 | SEC filing · Form 8-K | +0.25% | +0.25% | |
| Form 10-Q UroGen Pharma Ltd. For: Mar 31 | SEC filing · Form 10-Q | +3.43% | +14.14% | |
| Form 8-K UroGen Pharma Ltd. For: May 12 | SEC filing · Form 8-K | +3.43% | +14.14% | |
| Form 10-K/A UroGen Pharma Ltd. For: Dec 31 | SEC filing · Form 10-K | -0.78% | -1.04% | |
| Form 10-K UroGen Pharma Ltd. For: Dec 31 | SEC filing · Form 10-K | -0.46% | +10.75% | |
| Form 8-K UroGen Pharma Ltd. For: Mar 10 | SEC filing · Form 8-K | +5.49% | +8.89% | |
| Form 8-K UroGen Pharma Ltd. For: Feb 14 | SEC filing · Form 8-K | +0.09% | -1.83% | |
| Form 8-K UroGen Pharma Ltd. For: Jan 14 | SEC filing · Form 8-K | +0.20% | -3.03% | |
| Form 10-Q UroGen Pharma Ltd. For: Sep 30 | SEC filing · Form 10-Q | -4.45% | -7.62% | |
| Form 8-K UroGen Pharma Ltd. For: Nov 06 | SEC filing · Form 8-K | -4.45% | -7.62% | |
| Form 8-K UroGen Pharma Ltd. For: Oct 07 | SEC filing · Form 8-K | -0.58% | -8.54% | |
| Form 8-K UroGen Pharma Ltd. For: Sep 23 | SEC filing · Form 8-K | +0.27% | -1.23% | |
| Form 8-K UroGen Pharma Ltd. For: Sep 12 | SEC filing · Form 8-K | +0.00% | -0.38% | |
| Form 8-K UroGen Pharma Ltd. For: Aug 14 | SEC filing · Form 8-K | -0.84% | +0.65% | |
| Form 10-Q UroGen Pharma Ltd. For: Jun 30 | SEC filing · Form 10-Q | +1.48% | +5.50% | |
| Form 8-K UroGen Pharma Ltd. For: Aug 13 | SEC filing · Form 8-K | +1.48% | +5.50% | |
| Form S-8 UroGen Pharma Ltd. | SEC filing · Form S-8 | -1.53% | -2.77% | |
| Form 8-K UroGen Pharma Ltd. For: Aug 06 | SEC filing · Form 8-K | +0.00% | -2.53% | |
| Form ARS UroGen Pharma Ltd. For: Dec 31 | SEC filing · Form ARS | -0.48% | -1.74% | |
| Form DEF 14A UroGen Pharma Ltd. For: Aug 07 | SEC filing · Form DEF | -0.36% | -7.79% | |
| Form DEFA14A UroGen Pharma Ltd. | SEC filing · Form DEFA14A | -0.36% | -7.79% | |
| Form 8-K UroGen Pharma Ltd. For: Jun 17 | SEC filing · Form 8-K | -0.76% | -7.92% | |
| Form 8-K UroGen Pharma Ltd. For: Jun 13 | SEC filing · Form 8-K | — | +36.72% | |
| Form 10-Q UroGen Pharma Ltd. For: Mar 31 | SEC filing · Form 10-Q | +9.82% | +19.91% | |
| Form 8-K UroGen Pharma Ltd. For: May 13 | SEC filing · Form 8-K | +9.82% | +19.91% | |
| Form 10-K/A UroGen Pharma Ltd. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.27% | |
| Form 10-K UroGen Pharma Ltd. For: Dec 31 | SEC filing · Form 10-K | -0.27% | -14.55% | |
| Form 8-K UroGen Pharma Ltd. For: Mar 14 | SEC filing · Form 8-K | -0.27% | -14.55% | |
| Form 8-K UroGen Pharma Ltd. For: Mar 04 | SEC filing · Form 8-K | -2.40% | +2.90% | |
| Form 8-K UroGen Pharma Ltd. For: Mar 01 | SEC filing · Form 8-K | +0.49% | +2.60% | |
| Form 8-K UroGen Pharma Ltd. For: Feb 07 | SEC filing · Form 8-K | -0.12% | +13.36% | |
| Form 8-K UroGen Pharma Ltd. For: Jan 16 | SEC filing · Form 8-K | -1.47% | -8.93% | |
| Form 8-K UroGen Pharma Ltd. For: Dec 28 | SEC filing · Form 8-K | +0.13% | +1.60% | |
| Form 10-Q UroGen Pharma Ltd. For: Sep 30 | SEC filing · Form 10-Q | -3.78% | -4.03% | |
| Form 8-K UroGen Pharma Ltd. For: Nov 14 | SEC filing · Form 8-K | -3.78% | -4.03% | |
| Form S-8 UroGen Pharma Ltd. | SEC filing · Form S-8 | +0.00% | +0.26% |
Keep exploring
More URGN: earnings → · analyst actions → · URGN overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PolarityTE, Inc. (PTE) | 670 | -0.62% | 38% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 664 | -0.07% | 48% |
| Brainstorm Cell Therapeutics Inc. (BCLI) | 660 | 0.00% | 47% |
| OPHTHOTECH CORP COMMON (OPHT) | 660 | -0.20% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.